154 related articles for article (PubMed ID: 7559075)
1. VEGF-FLT1 receptor system: a new ligand-receptor system involved in normal and tumor angiogenesis.
Birnbaum D
Jpn J Cancer Res; 1995 Jul; 86(7):inside cover. PubMed ID: 7559075
[No Abstract] [Full Text] [Related]
2. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
3. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid-induced angiogenesis is VEGF-dependent.
Carter WB; Uy K; Ward MD; Hoying JB
Surgery; 2000 Sep; 128(3):458-64. PubMed ID: 10965318
[TBL] [Abstract][Full Text] [Related]
5. VEGFs, receptors and angiogenesis.
Veikkola T; Alitalo K
Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
[TBL] [Abstract][Full Text] [Related]
6. Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
[No Abstract] [Full Text] [Related]
7. Cartilage to bone--angiogenesis leads the way.
Harper J; Klagsbrun M
Nat Med; 1999 Jun; 5(6):617-8. PubMed ID: 10371495
[No Abstract] [Full Text] [Related]
8. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
[TBL] [Abstract][Full Text] [Related]
10. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinase signaling in vascular development.
Merenmies J; Parada LF; Henkemeyer M
Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
[No Abstract] [Full Text] [Related]
13. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
Plouet J
Ann Pathol; 1999; 19(5 Suppl):S70-1. PubMed ID: 10599456
[No Abstract] [Full Text] [Related]
14. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Ferrara N; Carver-Moore K; Chen H; Dowd M; Lu L; O'Shea KS; Powell-Braxton L; Hillan KJ; Moore MW
Nature; 1996 Apr; 380(6573):439-42. PubMed ID: 8602242
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
[TBL] [Abstract][Full Text] [Related]
17. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
Winther H; Ahmed A; Dantzer V
Placenta; 1999 Jan; 20(1):35-43. PubMed ID: 9950143
[TBL] [Abstract][Full Text] [Related]
19. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
